257 related articles for article (PubMed ID: 37626854)
21. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
[TBL] [Abstract][Full Text] [Related]
22. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
[TBL] [Abstract][Full Text] [Related]
23. The emerging roles of the CDK/cyclin complexes in antiviral innate immunity.
Zheng C; Tang YD
J Med Virol; 2022 Jun; 94(6):2384-2387. PubMed ID: 34964486
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
Morris MC; Divita G
J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
[TBL] [Abstract][Full Text] [Related]
25. A patent and literature review of CDK12 inhibitors.
Tang R; Liu J; Li S; Zhang J; Yu C; Liu H; Chen F; Lv L; Zhang Q; Yuan K; Shao H
Expert Opin Ther Pat; 2022 Oct; 32(10):1055-1065. PubMed ID: 36120913
[TBL] [Abstract][Full Text] [Related]
26. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
27. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
Santo L; Siu KT; Raje N
Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
[TBL] [Abstract][Full Text] [Related]
28. Control of G1 progression by D-type cyclins: key event for cell proliferation.
Kato JY
Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle control in isoproterenol-induced murine salivary acinar cell proliferation.
Zeng T; Yamamoto H; Bowen E; Broverman RL; Nguyen KH; Humphreys-Beher MG
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1996 Nov; 115(3):271-9. PubMed ID: 9375366
[TBL] [Abstract][Full Text] [Related]
30. Gene expression regulation by CDK12: a versatile kinase in cancer with functions beyond CTD phosphorylation.
Choi SH; Kim S; Jones KA
Exp Mol Med; 2020 May; 52(5):762-771. PubMed ID: 32451425
[TBL] [Abstract][Full Text] [Related]
31. The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.
Liao Y; Feng Y; Shen J; Hornicek FJ; Duan Z
Cancer Metastasis Rev; 2016 Jun; 35(2):151-63. PubMed ID: 26669603
[TBL] [Abstract][Full Text] [Related]
32. Targeting cyclin-dependent kinases in gastrointestinal cancer therapy.
Zhang J; Su G; Lin Y; Meng W; Lai JKL; Qiao L; Li X; Xie X
Discov Med; 2019 Jan; 27(146):27-36. PubMed ID: 30721649
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle molecular targets in novel anticancer drug discovery.
Buolamwini JK
Curr Pharm Des; 2000 Mar; 6(4):379-92. PubMed ID: 10788588
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D-CDK4/6 functions in cancer.
Gao X; Leone GW; Wang H
Adv Cancer Res; 2020; 148():147-169. PubMed ID: 32723562
[TBL] [Abstract][Full Text] [Related]
35. Mitotic timing is differentially controlled by A- and B-type cyclins and by CDC6 associated with a
El Dika M; Wechselberger L; Djeghout B; Benouareth DE; Jęderka K; Lewicki S; Zdanowski R; Prigent C; Kloc M; Kubiak JZ
Int J Dev Biol; 2021; 65(7-8-9):487-496. PubMed ID: 34549800
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic targets in cancer treatment: Cell cycle proteins.
Selvaraj C
Adv Protein Chem Struct Biol; 2023; 135():313-342. PubMed ID: 37061336
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
[TBL] [Abstract][Full Text] [Related]
38. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
Ravitz MJ; Wenner CE
Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
[TBL] [Abstract][Full Text] [Related]
39. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
[TBL] [Abstract][Full Text] [Related]
40. Current concepts in neuro-oncology: the cell cycle--a review.
Dirks PB; Rutka JT
Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
